This inventor holds 6 USPTO granted patents and 3 EPO patents. Top assignee: Kaneka Corporation. Active years: 2010-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2026
Title: Kohei Mori: Innovator in Pharmaceutical Chemistry
Introduction
Kohei Mori is a distinguished inventor based in Takasago, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work focuses on innovative methods for producing valuable pharmaceutical intermediates.
Latest Patents
Mori's latest patents include a method for producing tri-carbobenzoxy-arginine. This process involves carbobenzoxylating arginine or its derivatives using carbobenzoxy chloride and a base in a water/organic solvent bilayer system. Another notable patent is for a process to produce optically active α-methylcysteine derivatives. This invention provides a simple industrial method for obtaining L- or D-optically active α-methylcysteine derivatives from readily available raw materials, which are essential in pharmaceutical applications.
Career Highlights
Kohei Mori is currently employed at Kaneka Corporation, where he continues to advance his research and development efforts. His innovative approaches have positioned him as a key figure in the pharmaceutical industry.
Collaborations
Mori collaborates with talented coworkers, including Naoaki Taoka and Nobuo Nagashima. Their combined expertise fosters a productive environment for innovation and development.
Conclusion
Kohei Mori's contributions to pharmaceutical chemistry through his patents and collaborative efforts highlight his role as a significant inventor in the field. His work continues to impact the development of important pharmaceutical intermediates.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile